vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $77.6M, roughly 1.0× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -178.3%, a 168.7% gap on every dollar of revenue. On growth, Repay Holdings Corp posted the faster year-over-year revenue change (0.4% vs -16.8%). Over the past eight quarters, Repay Holdings Corp's revenue compounded faster (-1.3% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
BIOX vs RPAY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $78.6M |
| Net Profit | $-7.4M | $-140.1M |
| Gross Margin | 46.8% | 74.2% |
| Operating Margin | 9.3% | -182.2% |
| Net Margin | -9.6% | -178.3% |
| Revenue YoY | -16.8% | 0.4% |
| Net Profit YoY | -20.2% | -3304.1% |
| EPS (diluted) | $-0.12 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $78.6M | ||
| Q3 25 | $77.6M | $77.7M | ||
| Q2 25 | — | $75.6M | ||
| Q1 25 | $60.6M | $77.3M | ||
| Q4 24 | $98.8M | $78.3M | ||
| Q3 24 | $93.3M | $79.1M | ||
| Q2 24 | — | $74.9M | ||
| Q1 24 | $84.0M | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $-7.4M | $-6.4M | ||
| Q2 25 | — | $-102.3M | ||
| Q1 25 | $-1.6M | $-7.9M | ||
| Q4 24 | $605.2K | $-4.1M | ||
| Q3 24 | $-6.2M | $3.2M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | $9.8M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | 46.8% | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | 39.4% | 75.9% | ||
| Q4 24 | 42.0% | 76.3% | ||
| Q3 24 | 40.2% | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | 50.8% | 76.2% |
| Q4 25 | — | -182.2% | ||
| Q3 25 | 9.3% | -3.9% | ||
| Q2 25 | — | -138.7% | ||
| Q1 25 | 1.5% | -4.7% | ||
| Q4 24 | 14.5% | -1.5% | ||
| Q3 24 | 2.5% | -0.9% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | 15.7% | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | -9.6% | -8.3% | ||
| Q2 25 | — | -135.2% | ||
| Q1 25 | -2.6% | -10.3% | ||
| Q4 24 | 0.6% | -5.3% | ||
| Q3 24 | -6.6% | 4.1% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | 11.6% | -6.5% |
| Q4 25 | — | $-1.68 | ||
| Q3 25 | $-0.12 | $-0.08 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | $-0.02 | $-0.09 | ||
| Q4 24 | $0.00 | $-0.04 | ||
| Q3 24 | $-0.10 | $0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | $0.14 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $288.3M | $484.4M |
| Total Assets | $734.9M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $115.7M | ||
| Q3 25 | $15.5M | $95.7M | ||
| Q2 25 | — | $162.6M | ||
| Q1 25 | $38.5M | $165.5M | ||
| Q4 24 | $29.2M | $189.5M | ||
| Q3 24 | $32.3M | $168.7M | ||
| Q2 24 | — | $147.1M | ||
| Q1 24 | $16.4M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | — | $484.4M | ||
| Q3 25 | $288.3M | $616.9M | ||
| Q2 25 | — | $633.7M | ||
| Q1 25 | $345.0M | $755.7M | ||
| Q4 24 | $346.3M | $761.3M | ||
| Q3 24 | $346.0M | $754.7M | ||
| Q2 24 | — | $815.4M | ||
| Q1 24 | $348.5M | $813.8M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $734.9M | $1.3B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | $798.2M | $1.5B | ||
| Q4 24 | $835.2M | $1.6B | ||
| Q3 24 | $827.3M | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $836.1M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $23.3M |
| Free Cash FlowOCF − Capex | — | $23.2M |
| FCF MarginFCF / Revenue | — | 29.6% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.3M | ||
| Q3 25 | $14.4M | $32.2M | ||
| Q2 25 | — | $33.1M | ||
| Q1 25 | $23.3M | $2.5M | ||
| Q4 24 | $-5.4M | $34.3M | ||
| Q3 24 | $5.2M | $60.1M | ||
| Q2 24 | — | $31.0M | ||
| Q1 24 | $-17.4M | $24.8M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
